Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | CASP3 | P42574 | 1/20 | 0.31 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.31 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.31 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26370528 | 0.95 | CA1 (0.33) | CA1CA2CA7CA9SMN1; SMN2 | |
| SCHEMBL21117420 | 0.88 | ALDH1A1 (0.42) | CA1CA2CA7CA9SMN1; SMN2 | |
| Dimethylamine SCHEMBL1996640 | 0.86 | CA2 (0.37) | CA1CA2CA9SMN1; SMN2ALDH1A1 | |
| SCHEMBL26370527 | 0.85 | CA1 (0.34) | CA1CA2CA7CA9SMN1; SMN2 | |
| SCHEMBL29331693 | 0.84 | ALDH1A1 (0.39) | CA2SMN1; SMN2ALDH1A1KDM4EALOX15 | |
| SCHEMBL26370525 | 0.82 | ALDH1A1 (0.39) | SMN1; SMN2ALDH1A1KDM4EKMT2A | |
| SCHEMBL21117421 | 0.82 | CA12 (0.44) | CA1CA2CA7CA9KDM4E | |
| SCHEMBL29331562 | 0.82 | — | — | |
| SCHEMBL20960341 | 0.79 | ALDH1A1 (0.34) | ALDH1A1KDM4EKMT2A | |
| SCHEMBL1996638 | 0.79 | ALDH1A1 (0.41) | CA1CA2CA9SMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894876-B2 | Method for producing modified conjugated diene-based polymer, modified conjugated diene-based polymer, polymer composition, crosslinked body, tire and compound | JSR CORPORATION (JP) | 2021-01-19 | — | — | US | disclosed |
| US-20190194430-A1 | METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE-BASED POLYMER, MODIFIED CONJUGATED DIENE-BASED POLYMER, POLYMER COMPOSITION, CROSSLINKED BODY, TIRE AND COMPOUND | JSR CORPORATION (JP) | 2019-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894876-B2 | Method for producing modified conjugated diene-based polymer, modified conjugated diene-based polymer, polymer composition, crosslinked body, tire and compound | IGF1R, PHOSPHO1, GAR1 | CA1 169/4885CA2 1394/4885CA7 498/4885 |
| US-20190194430-A1 | METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE-BASED POLYMER, MODIFIED CONJUGATED DIENE-BASED POLYMER, POLYMER COMPOSITION, CROSSLINKED BODY, TIRE AND COMPOUND | IGF1R, PHOSPHO1, GAR1 | CA1 120/4885CA2 1266/4885CA7 443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.